Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 2, 2026European Journal Of HaematologyOpen Access

Bone Marrow Fibrosis as a Predictor of Extramedullary Disease in Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHilal SenkalAAAli Yılmaz AltayEIEmine Göknur Işık

Discussion

Loading...

Member takes

Overview

Retrospective cohort study reveals bone marrow fibrosis predicts synchronous extramedullary disease in multiple myeloma, highlighting marrow scarring as a clinical marker for tumor spread.

Key Points

  • To determine the incidence of bone marrow fibrosis in newly diagnosed multiple myeloma and evaluate its relationship with synchronous soft tissue extramedullary disease at diagnosis.
  • Conducted a retrospective chart review of 356 patients with multiple myeloma to evaluate clinical characteristics, histological features, and treatment outcomes.
  • Graded bone marrow fibrosis (BMF) using WHO criteria, categorizing Grade 2–3 as the fibrosis group and Grade 0–1 as the non-fibrosis group, alongside identifying extramedullary disease originating from hematogenous spread.
  • Grade 2 or higher BMF was observed in 146 of 356 patients (41.0%) and was present in 40 of the 52 patients with extramedullary disease (p < 0.01).
  • Multivariable logistic regression identified BMF status as an independent predictor of synchronous extramedullary disease (OR = 3.200, 95% CI: 1.010–10.141, p = 0.048).
  • Elevated serum lactate dehydrogenase levels independently predicted synchronous extramedullary involvement (OR = 1.003, 95% CI: 1.000–1.005, p = 0.037).

Cite This Study

Senkal et al. (2026) studied this question.

synapsesocial.com/papers/6a97e2d9c562ede874ec73b7https://doi.org/10.1111/ejh.70314
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors2024 · 4 citations
  2. 2Factors Affecting Prognosis in Patients with Extramedullary Myeloma: A Single-Center Experience2026
  3. 3Primary Myelofibrosis vs. Multiple Myeloma-Associated Bone Marrow Fibrosis: When Treatment Response Clarifies the Diagnosis2026
  4. 4Prognostic significance of bone marrow fibrosis in diffuse large B‐cell lymphoma2024 · 1 citations
  5. 5Impact of bone marrow fibrosis on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia2024 · 5 citations